2018 AAP指南:基层医疗中青少年抑郁症的管理

2018-02-26 美国儿科学会 Pediatrics. 2018 Feb 26.

2018年2月,美国儿科学会(AAP)发布了基层医疗中青少年抑郁症的管理指南,该指南是对青少年抑郁症基层医师管理指南的更新,主要包括两大部分内容,分别为:实践准备,识别,评估,和初始管理以及青少年抑郁症的治疗和持续管理。

中文标题:

2018 AAP指南:基层医疗中青少年抑郁症的管理

英文标题:

Guidelines for Adolescent Depression in Primary Care (GLAD-PC)

发布机构:

美国儿科学会

发布日期:

2018-02-26

简要介绍:

2018年2月,美国儿科学会(AAP)发布了基层医疗中青少年抑郁症的管理指南,该指南是对青少年抑郁症基层医师管理指南的更新,主要包括两大部分内容,分别为:实践准备,识别,评估,和初始管理以及青少年抑郁症的治疗和持续管理。

 

拓展指南:抑郁症相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2018 AAP指南:基层医疗中青少年抑郁症的管理)] GetToolGuiderByIdResponse(projectId=1, id=19d8b1c0015628c0, title=2018 AAP指南:基层医疗中青少年抑郁症的管理, enTitle=Guidelines for Adolescent Depression in Primary Care (GLAD-PC), guiderFrom=Pediatrics. 2018 Feb 26., authorId=null, author=, summary=2018年2月,美国儿科学会(AAP)发布了基层医疗中青少年抑郁症的管理指南,该指南是对青少年抑郁症基层医师管理指南的更新,主要包括两大部分内容,分别为:实践准备,识别,评估,和初始管理以及青少年抑郁症的治疗和持续管理。 , cover=, journalId=null, articlesId=null, associationId=119, associationName=美国儿科学会, associationIntro=null, copyright=0, guiderPublishedTime=Mon Feb 26 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<P>2018年2月,美国儿科学会(AAP)发布了基层医疗中青少年抑郁症的管理指南,该指南是对青少年抑郁症基层医师管理指南的更新,主要包括两大部分内容,分别为:实践准备,识别,评估,和初始管理以及青少年抑郁症的治疗和持续管理。 </P> <P> </P>拓展指南:<strong>与<font color=red>抑郁症</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=6992d1c001a89662" title="2017 佛罗里达最佳实践指南:成人抑郁症的药物治疗" target=_blank>2017 佛罗里达最佳实践指南:成人抑郁症的药物治疗</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=b82b41c001a486c6" title="2017 APA共识建议:重复经颅刺激(rTMS)治疗抑郁症的临床应用" target=_blank>2017 APA共识建议:重复经颅刺激(rTMS)治疗抑郁症的临床应用</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=f8f9d1c001390ec9" title="【专题】 应对抑郁症,让医患“零”压力的神器竟然是这个!!!" target=_blank>【专题】 应对抑郁症,让医患“零”压力的神器竟然是这个!!!</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=c0a951c00128308b" title="2015 BAP循证指南:抗抑郁药治疗抑郁症(修订2008版)" target=_blank>2015 BAP循证指南:抗抑郁药治疗抑郁症(修订2008版)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=4e7c41c001282998" title="2015 AHA科学声明:重度抑郁症和双相情感障碍会导致年轻人加速性动脉粥样硬化和早期心血管疾病  " target=_blank>2015 AHA科学声明:重度抑郁症和双相情感障碍会导致年轻人加速性动脉粥样硬化和早期心血管疾病  </a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E6%8A%91%E9%83%81%E7%97%87" target=_blank>有关抑郁症更多指南</a></ul>, tagList=[TagDto(tagId=71008, tagName=青少年抑郁障碍), TagDto(tagId=228, tagName=抑郁症)], categoryList=[CategoryDto(categoryId=13, categoryName=精神心理科, tenant=100), CategoryDto(categoryId=18, categoryName=儿科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=1, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=8589, appHits=311, showAppHits=0, pcHits=5874, showPcHits=3258, likes=175, shares=11, comments=8, approvalStatus=1, publishedTime=Sat Mar 03 21:14:32 CST 2018, publishedTimeString=2018-02-26, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sat Mar 03 21:14:32 CST 2018, updatedBy=null, updatedName=null, updatedTime=Wed Jan 03 21:52:50 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 AAP指南:基层医疗中青少年抑郁症的管理)])
2018 AAP指南:基层医疗中青少年抑郁症的管理
下载请点击:
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2157355, encodeId=f4a6215e3553b, content=非常好 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/aASBQoxCmhVBV57Eh0JJVRMblS7dxibyZkcfRUFfwrKTepghcocy3r6oaKCibStE1KDNDWjFxSpWZHfR3TezwoZg/132, createdBy=362f5290879, createdName=ms3278789579196637, createdTime=Tue Sep 12 16:03:32 CST 2023, time=2023-09-12, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2110621, encodeId=6429211062101, content=点赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3fed8347031, createdName=ms2000001919244412, createdTime=Tue Jan 17 21:11:56 CST 2023, time=2023-01-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2110620, encodeId=30b5211062099, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3fed8347031, createdName=ms2000001919244412, createdTime=Tue Jan 17 21:11:47 CST 2023, time=2023-01-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2099582, encodeId=b5fe209958292, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210420/09716af288084795ba128059da55a818/c3137a18601c4c54bb7d71ac97630870.jpg, createdBy=e9985480565, createdName=ozzy, createdTime=Thu Nov 10 11:26:29 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901609, encodeId=37e1901609cd, content=好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210906/e141ddca670e4042bffbf47e00f8d2fd/b6517df71dfe42cb979aacdc454225cc.jpg, createdBy=0c532181739, createdName=12074e34m25(暂无昵称), createdTime=Mon Nov 23 23:25:46 CST 2020, time=2020-11-23, status=1, ipAttribution=)]
    2023-09-12 ms3278789579196637 来自山西省

    非常好

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2157355, encodeId=f4a6215e3553b, content=非常好 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/aASBQoxCmhVBV57Eh0JJVRMblS7dxibyZkcfRUFfwrKTepghcocy3r6oaKCibStE1KDNDWjFxSpWZHfR3TezwoZg/132, createdBy=362f5290879, createdName=ms3278789579196637, createdTime=Tue Sep 12 16:03:32 CST 2023, time=2023-09-12, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2110621, encodeId=6429211062101, content=点赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3fed8347031, createdName=ms2000001919244412, createdTime=Tue Jan 17 21:11:56 CST 2023, time=2023-01-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2110620, encodeId=30b5211062099, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3fed8347031, createdName=ms2000001919244412, createdTime=Tue Jan 17 21:11:47 CST 2023, time=2023-01-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2099582, encodeId=b5fe209958292, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210420/09716af288084795ba128059da55a818/c3137a18601c4c54bb7d71ac97630870.jpg, createdBy=e9985480565, createdName=ozzy, createdTime=Thu Nov 10 11:26:29 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901609, encodeId=37e1901609cd, content=好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210906/e141ddca670e4042bffbf47e00f8d2fd/b6517df71dfe42cb979aacdc454225cc.jpg, createdBy=0c532181739, createdName=12074e34m25(暂无昵称), createdTime=Mon Nov 23 23:25:46 CST 2020, time=2020-11-23, status=1, ipAttribution=)]
    2023-01-17 ms2000001919244412 来自湖北省

    点赞

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2157355, encodeId=f4a6215e3553b, content=非常好 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/aASBQoxCmhVBV57Eh0JJVRMblS7dxibyZkcfRUFfwrKTepghcocy3r6oaKCibStE1KDNDWjFxSpWZHfR3TezwoZg/132, createdBy=362f5290879, createdName=ms3278789579196637, createdTime=Tue Sep 12 16:03:32 CST 2023, time=2023-09-12, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2110621, encodeId=6429211062101, content=点赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3fed8347031, createdName=ms2000001919244412, createdTime=Tue Jan 17 21:11:56 CST 2023, time=2023-01-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2110620, encodeId=30b5211062099, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3fed8347031, createdName=ms2000001919244412, createdTime=Tue Jan 17 21:11:47 CST 2023, time=2023-01-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2099582, encodeId=b5fe209958292, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210420/09716af288084795ba128059da55a818/c3137a18601c4c54bb7d71ac97630870.jpg, createdBy=e9985480565, createdName=ozzy, createdTime=Thu Nov 10 11:26:29 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901609, encodeId=37e1901609cd, content=好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210906/e141ddca670e4042bffbf47e00f8d2fd/b6517df71dfe42cb979aacdc454225cc.jpg, createdBy=0c532181739, createdName=12074e34m25(暂无昵称), createdTime=Mon Nov 23 23:25:46 CST 2020, time=2020-11-23, status=1, ipAttribution=)]
    2023-01-17 ms2000001919244412 来自湖北省

    不错

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2157355, encodeId=f4a6215e3553b, content=非常好 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/aASBQoxCmhVBV57Eh0JJVRMblS7dxibyZkcfRUFfwrKTepghcocy3r6oaKCibStE1KDNDWjFxSpWZHfR3TezwoZg/132, createdBy=362f5290879, createdName=ms3278789579196637, createdTime=Tue Sep 12 16:03:32 CST 2023, time=2023-09-12, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2110621, encodeId=6429211062101, content=点赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3fed8347031, createdName=ms2000001919244412, createdTime=Tue Jan 17 21:11:56 CST 2023, time=2023-01-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2110620, encodeId=30b5211062099, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3fed8347031, createdName=ms2000001919244412, createdTime=Tue Jan 17 21:11:47 CST 2023, time=2023-01-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2099582, encodeId=b5fe209958292, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210420/09716af288084795ba128059da55a818/c3137a18601c4c54bb7d71ac97630870.jpg, createdBy=e9985480565, createdName=ozzy, createdTime=Thu Nov 10 11:26:29 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901609, encodeId=37e1901609cd, content=好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210906/e141ddca670e4042bffbf47e00f8d2fd/b6517df71dfe42cb979aacdc454225cc.jpg, createdBy=0c532181739, createdName=12074e34m25(暂无昵称), createdTime=Mon Nov 23 23:25:46 CST 2020, time=2020-11-23, status=1, ipAttribution=)]
    2022-11-10 ozzy

    非常好

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2157355, encodeId=f4a6215e3553b, content=非常好 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/aASBQoxCmhVBV57Eh0JJVRMblS7dxibyZkcfRUFfwrKTepghcocy3r6oaKCibStE1KDNDWjFxSpWZHfR3TezwoZg/132, createdBy=362f5290879, createdName=ms3278789579196637, createdTime=Tue Sep 12 16:03:32 CST 2023, time=2023-09-12, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2110621, encodeId=6429211062101, content=点赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3fed8347031, createdName=ms2000001919244412, createdTime=Tue Jan 17 21:11:56 CST 2023, time=2023-01-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2110620, encodeId=30b5211062099, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3fed8347031, createdName=ms2000001919244412, createdTime=Tue Jan 17 21:11:47 CST 2023, time=2023-01-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2099582, encodeId=b5fe209958292, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210420/09716af288084795ba128059da55a818/c3137a18601c4c54bb7d71ac97630870.jpg, createdBy=e9985480565, createdName=ozzy, createdTime=Thu Nov 10 11:26:29 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901609, encodeId=37e1901609cd, content=好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210906/e141ddca670e4042bffbf47e00f8d2fd/b6517df71dfe42cb979aacdc454225cc.jpg, createdBy=0c532181739, createdName=12074e34m25(暂无昵称), createdTime=Mon Nov 23 23:25:46 CST 2020, time=2020-11-23, status=1, ipAttribution=)]
    2020-11-23 12074e34m25(暂无昵称)

    好好

    0